Scientists at the University of New Mexico have advanced a tau-targeting Alzheimer’s vaccine into human trials. It triggered strong immune reactions and cleared pathological tau protein in both mice and rhesus macaques — slowing neurodegeneration and improving cognition. A Phase 1 clinical trial is slated for early 2026 to assess safety and immune response in humans. This could mark the first step toward a true disease-modifying treatment. Could this be the breakthrough Alzheimer’s patients have been waiting for? For more content like this, please visit: https://t.co/wYpbt8knJz #alzheimersresearch# #tauvaccine# #medicalinnovation# #neuroscience#

Scientists have discovered a link between gum disease and Alzheimer’s. The bacteria Porphyromonas gingivalis, known for causing chronic periodontitis, has been found in the brains of Alzheimer’s patients. In mice, it triggered amyloid beta buildup — a key hallmark of the disease. This raises the possibility that infection and inflammation may play a larger role in neurodegeneration than we thought. For more content like this, please visit: https://t.co/aarOCkIins #AlzheimersResearch# #BrainHealth# #OralHealthMatters# #Neurodegeneration#